论文部分内容阅读
造血干细胞损伤和缺陷是再生障碍性贫血(下称再障)三大发病机理之一。补充造血干细胞的来源有骨髓、外周血细胞和胎肝。国内自1963年潘瑞彭报告胎儿造血组织移植以来,随着实验血液学和免疫学的发展,对胎肝移植治疗再障屡有报道。我科自1982年8月以来用胎肝细胞悬液输注(下称FLT)治疗17例再障,取得一定疗效,现报告如下。材料与方法一、病例选择17例慢性再障均符合1981年河北廊坊“全国再障座谈会”商定的诊断标准。其中男性8
Hematopoietic stem cell damage and defects are one of the three major pathogenesis of aplastic anemia (hereinafter referred to as aplastic anemia). The sources of hematopoietic stem cells are bone marrow, peripheral blood cells and fetal liver. Since the report of Pan Ruipeng transplantation of fetal hematopoietic tissue in China in 1963, with the development of experimental hematology and immunology, aplastic anemia of fetal liver transplantation has been reported frequently. Our department from August 1982 since fetal liver cell suspension infusion (hereinafter referred to as FLT) treatment of 17 cases of aplastic anemia, and achieved some curative effect, are as follows. Materials and methods A case selection 17 cases of chronic aplastic anemia are in line with 1981, Langfang, Hebei “national aplastic anemia discussion” agreed diagnostic criteria. Among them, male 8